Blog
RSS FeedPosted by Michael Wonder on 07 Dec 2018
Surviving niche busters: Main strategies employed by Canadian private insurers facing the arrival of high cost specialty drugs
6 December 2018 - The Canadian patchwork system of prescription drug coverage and the employer sponsored private health benefits group plans ...
Posted by Michael Wonder on 07 Dec 2018
Proposal to list a new presentation of raltegravir and amend arrangements for raltegravir and posaconazole
7 December 2018 - PHARMAC is seeking feedback on a multi-product proposal with Merck Sharpe & Dohme. ...
Posted by Michael Wonder on 07 Dec 2018
Underuse of innovative medicines in Germany: A justification for government intervention?
6 December 2018 - The German market for innovative medicines is characterised by simultaneous underuse and overuse. ...
Posted by Michael Wonder on 06 Dec 2018
Long waits push surgeries onto private health insurance list
6 December 2018 - The long wait for hip and knee replacements and cataract surgery in the public hospital system ...
Posted by Michael Wonder on 06 Dec 2018
Trapped abroad: NZ a 'death sentence' if she comes home
6 December 2018 - Rachel Paine never meant to settle overseas but coming home risks death. ...
Posted by Michael Wonder on 05 Dec 2018
PHARMAC - 2018 in review (update)
6 December 2018 - Further analysis of the ten new patent protected medicines (i.e. new chemical entities) listed in the ...
Posted by Michael Wonder on 05 Dec 2018
NICE terminates two appraisals
5 December 2018 - NICE is unable to make a recommendation about the use of two medicines in the NHS because ...
Posted by Michael Wonder on 05 Dec 2018
NHS to save £1 billion on its medicines bill in 2019
5 December 2018 - The NHS is expected to save around £930 million on its medicines bill across the UK ...
Posted by Michael Wonder on 04 Dec 2018
Flexibility on cancer drugs approval will foster innovation
4 December 2018 - Between 2000 and 2016, no new drugs were approved for cancers of the brain, and there were ...
Posted by Michael Wonder on 04 Dec 2018
New cancer drugs taking longer to reach NHS patients
4 December 2018 - NHS patients are waiting longer for new cancer drugs because of delays in taking them through ...
Posted by Michael Wonder on 04 Dec 2018
Mulholland supports calls for PHARMAC Inquiry
4 December 2018 - Stage four breast cancer sufferer Wiki Mulholland is supporting calls for an Inquiry into PHARMAC. ...
Posted by Michael Wonder on 04 Dec 2018
NICE backs Cimzia for psoriasis, but rejects Ilumetri
4 December 2018 - Cost watchdog NICE has backed NHS funding for UCB’s Cimzia as a treatment for psoriasis, but ...
Posted by Michael Wonder on 04 Dec 2018
Enstilar is now covered by the Alberta Drug Benefit List for adults with psoriasis vulgaris
3 December 2018 - Leo Pharma Canada has announced that as of 1 December 2018, Enstilar has been added as ...
Posted by Michael Wonder on 04 Dec 2018
Medicines for severe asthma and growth hormone deficiency listed on the PBS
1 December 2018 - The Australian Government will list new medicines for severe asthma, and severe growth hormone deficiency on the ...
Posted by Michael Wonder on 03 Dec 2018
PHARMAC - 2018 in review
4 December 2018 - Yet another disappointing year in terms of patients in New Zealand being able to obtain subsidised ...